More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Recombinant SARS-COV-2 Spike RBD (N501Y, K417N, E484K) Protein
Recombinant SARS-CoV-2 Spike RBD (N501Y, K417N, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-CoV-2 Spike RBD (N501Y, K417N, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-CoV-2 Spike RBD (N501Y, K417N, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

Recombinant SARS-COV-2 Spike RBD (N501Y, K417N, E484K) Protein

Research Use Only
BS-46018P
Bioss Antibodies
ApplicationsWestern Blot, ELISA, Other Application
Product group Proteins / Signaling Molecules
Price on request
Packing Size
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Bioss Antibodies
  • Product Name
    Recombinant SARS-COV-2 Spike RBD (N501Y, K417N, E484K) Protein
  • Delivery Days Customer
    16
  • Applications
    Western Blot, ELISA, Other Application
  • Certification
    Research Use Only
  • Conjugate
    Unconjugated
  • Estimated Purity
    >95%
  • Scientific Description
    SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as a receptor to invade cells. It has been reported that the UK and South African strains may have higher transmission capabilities, eventually in part due to amino acid substitutions on the SARS-CoV-2 Spike protein. The results of a study show the N501Y replacement in this region of the interface (present in both the UK and South African strains) should be favorable for the interaction with ACE2, while the K417N and E484K substitutions (South African strain) would seem neutral or even unfavorable.
  • Storage Instruction
    -80°C
  • UNSPSC
    12352202